DermNet provides Google Translate, a free machine translation service. Note that this may not provide an exact translation in all languages
Author: Vanessa Ngan, Staff Writer, 2005.
Podophyllin resin is a substance derived from the roots of the mayapple plant (Podophyllum peltatum) that grows in the wild in eastern North America. The resin is the crude alcohol extract of the plant's rhizome or underground root system and is essentially made up of 4 different components: podophyllotoxin, 4-demethylpodophyllotoxin, a-peltatin, and b-peltatin. Podophyllotoxin is the most biologically active component and has been used for centuries by Native Americans for its medicinal properties.
A second species, Podophyllum hexandrum, grown in the mountain regions of India has been found to contain much more of the active component podophyllotoxin.
Podophyllotoxin is an antimitotic. It acts by preventing viral wart cells from dividing and multiplying. Eventually all the wart cells die and new healthy cells grow in their place.
For centuries, Native American tribes used the plant and its root for its medicinal, as well as poisonous, properties. Various uses of the plant included:
In the 1930s, doctors in New Orleans started using podophyllotoxin for the treatment of genital warts. By 1942 the first description of this practice was published in medical literature.
In New Zealand, podophyllotoxin is a prescription medicine and available as a 0.15% w/w cream (Wartec™) and 5mg/ml solution (Condyline™) for the treatment of external condylomata acuminata (anogenital warts). It is not recommended for internal use or for extensive warts (more than 10 square centimetres).
Because of its potential to damage healthy skin cells, podophyllotoxin preparations should only be used as directed.
Podophyllotoxin should not be used in pregnant women as human and animal studies have shown that the resin may be harmful to the fetus when used in pregnancy.
It is not known whether topical podophyllotoxin passes into breast milk, hence use of this resin during breastfeeding is not recommended unless the benefits far outweigh the risks.
Podophyllotoxin should not be applied to open wounds or bleeding sites.
Podophyllotoxin preparations contain alcohol and therefore may be flammable. Do not use near heat, open flame or while smoking.
The initial application of podophyllotoxin on the wart does not hurt but local irritation may occur on the second or third day of treatment when necrosis of the wart starts. Patients can expect tenderness, redness, itching, slight pain and superficial ulceration of the outer layer of the skin in treated areas. These local effects decrease after treatment or can be minimised after a few days of using a topical corticosteroid.
Other side effects include burning and/or bleeding of treated skin, dizziness, headache, and vomiting. Patients should see their doctor if these side effects occur or if local effects worsen.
See the DermNet NZ bookstore
© 2020 DermNet New Zealand Trust.
DermNet NZ does not provide an online consultation service. If you have any concerns with your skin or its treatment, see a dermatologist for advice.